Literature DB >> 7447432

High-pressure liquid chromatographic method for determination of rosaramicin in humans.

C Lin, H Kim, D Schuessler, E Oden, S Symchowicz.   

Abstract

A high-pressure liquid chromatographic method has been developed for the quantitative determination of rosaramicin in serum. This procedure involves addition of an internal standard, adjustment to alkaline pH, treatment with potassium carbonate, ether extraction, and a reverse-phase column separation with acetonitrile-acetate buffer mixture as the mobile phase. This technique produces a good linear relationship between the peak height ratio and the rosaramicin concentration. In addition, this method has proven to be quite specific for rosaramicin, since many of its derivatives tested do not interfere with the assay. The method is accurate and reproducible with a sensitivity of about 0.01 microgram of rosaramicin per ml of serum. It may be useful in monitoring drug levels in serum of patients and also for the pharmacokinetic studies of the drug in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447432      PMCID: PMC284091          DOI: 10.1128/AAC.18.5.780

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  High-pressure liquid chromatographic assay of netilmicin in plasma.

Authors:  G W Peng; G G Jackson; W L Chiou
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  Rosamicin in urethral and vaginal secretions and tissues in dogs and rats.

Authors:  U Hoyme; A Baumueller; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

4.  A new Micromonospora-produced macrolide antibiotic, rosamicin.

Authors:  G H Wagman; J A Waitz; J Marquez; A Murawaski; E M Oden; R T Testa; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

5.  Rosamicin--a new drug for the treatment of bacterial prostatitis.

Authors:  A Baumueller; U Hoyme; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

6.  High-pressure liquid chromatography analysis and single-dose disposition of tobramycin in human volunteers.

Authors:  D B Haughey; D M Janicke; M Adelman; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

  6 in total
  3 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.

Authors:  C C Lin; H K Kim; A Marco; E Radwanski; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Pharmacokinetics and metabolism of rosaramicin in humans.

Authors:  C C Lin; M Chung; R Gural; D Schuessler; H K Kim; E Radwanski; A Marco; C DiGiore; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.